HNRNPL and chronic myelogenous leukemia, BCR-ABL1 positive: Although aberrant expression and activity of certain hnRNPs have been already described [35], [36], suggesting that they may act as oncogenic factors [37], [38], the role of hnRNP L in CML is still largely unexplored.